The stock has "Buy" rating by Canaccord Genuity on Friday, December 4. The stock of Twitter, Inc. Credit Suisse maintained it with "Buy" rating and $261.0 target in Thursday, November 9 report. Credit Suisse downgraded it to "Hold" rating and $14000 target in Wednesday, July 12 report. The company was maintained on Wednesday, November 25 by Wunderlich. The rating was downgraded by Credit Suisse to "Hold" on Wednesday, July 12. The company is given one point for every criteria that is met and no points if not met.
National Asset Management Inc increased its stake in Align Technology Inc (ALGN) by 54.6% based on its latest 2017Q3 regulatory filing with the SEC.
Align Technology Inc (NASDAQ:ALGN) is considered a high growth stock, but some investors are starting to doubt its last closing price of $252.91 can be still justified by the high growth potential. The institutional investor held 130,272 shares of the health care company at the end of 2017Q3, valued at $24.27M, up from 124,782 at the end of the previous reported quarter. Keybank National Association who had been investing in Align Technology Inc for a number of months, seems to be bullish on the $20.06B market cap company. Commonwealth Bank of Australia now owns 1,129 shares of the medical equipment provider's stock valued at $169,000 after purchasing an additional 107 shares during the last quarter. About 893,102 shares traded. Marriott International, Inc. (NASDAQ:MAR) has risen 58.26% since January 13, 2017 and is uptrending. It has outperformed by 65.52% the S&P500. The stock increased 0.25% or $0.35 during the last trading session, reaching $139.78. About 19.01M shares traded. YuMe, Inc. (NYSE:YUME) has risen 17.98% since January 12, 2017 and is uptrending. It has outperformed by 75.03% the S&P500.
Investors sentiment increased to 1.63 in Q3 2017. Its up 0.20, from 1.6 in 2017Q2. It also reduced its holding in Qualcomm Inc (NASDAQ:QCOM) by 26,619 shares in the quarter, leaving it with 828,759 shares, and cut its stake in Alza Corp.
Other hedge funds have also made changes to their positions in the company. Syntal Cap Ptnrs Lc reported 4,719 shares. (NYSE:YUME). Spark Investment Limited Liability Com owns 316,700 shares for 0.08% of their portfolio. Moreover, Susquehanna Interest Gru Limited Liability Partnership has 0% invested in YuMe, Inc. (NYSE:YUME) for 977,463 shares. Insiders sold 52,849 shares of company stock valued at $13,494,348 over the last quarter. Deutsche Commercial Bank Ag invested in 0.03% or 216,384 shares. QS Investors LLC now owns 2,729 shares of the medical equipment provider's stock worth $410,000 after buying an additional 123 shares during the period.
Sheets Smith Wealth Management, which manages about $700.54 million and $396.50 million US Long portfolio, upped its stake in American Tower Corp New (NYSE:AMT) by 3,735 shares to 5,879 shares, valued at $804,000 in 2017Q3, according to the filing.
YuMe, Inc. (YUME) formed H&S with $4.15 target or 6.00% below today's $4.41 share price. (NYSE:YUME). Acadian Asset Mngmt Limited Com, a Massachusetts-based fund reported 987,265 shares. 1,570 are held by Plante Moran Finance Advsrs. (NASDAQ:ALGN). Goldman Sachs Gp reported 1.48M shares stake. (NASDAQ:ALGN). The California-based Clarivest Asset Mgmt Ltd Liability has invested 0% in Align Technology, Inc. (NYSE:ECC). Mycio Wealth Prtnrs Ltd Liability owns 1.15 million shares for 2.7% of their portfolio. Therefore 67% are positive. Intertek Group PLC had 180 analyst reports since July 27, 2015 according to SRatingsIntel. Stifel Nicolaus maintained the shares of ALGN in report on Monday, September 11 with "Buy" rating.
Align Technology, Inc designs, manufactures and markets a system of clear aligner therapy, intra-oral scanners and computer-aided design and computer-aided manufacturing (CAD/CAM) digital services used in dentistry, orthodontics and dental records storage. (NASDAQ:ALGN) has "Buy" rating given on Friday, July 28 by Roth Capital. Robert W. Baird maintained it with "Buy" rating and $200.0 target in Monday, September 11 report. Credit Suisse initiated Align Technology, Inc. (NASDAQ:ALGN) rating on Wednesday, September 13. The rating was maintained by Leerink Swann with "Outperform" on Friday, July 28. The company was maintained on Monday, December 4 by Leerink Swann. (NYSE:YUME) has "Overweight" rating given on Tuesday, August 11 by Piper Jaffray. (NYSE:YUME) has "Neutral" rating given on Wednesday, August 10 by Citigroup. BMO Capital Markets maintained it with "Hold" rating and $17.0 target in Monday, October 16 report. The medical equipment provider reported $1.01 EPS for the quarter, topping analysts' consensus estimates of $0.82 by $0.19. Its down 0.26, from 1.71 in 2017Q2. It dived, as 36 investors sold ALGN shares while 194 reduced holdings. 12 funds opened positions while 38 raised stakes. During the same period last year, the firm posted $0.63 earnings per share. equities analysts anticipate that Align Technology, Inc. will post 3.67 EPS for the current fiscal year. (NASDAQ:ALGN). Ledyard State Bank accumulated 129 shares. Morgan Stanley maintained Align Technology, Inc. (NASDAQ:ALGN) for 21,760 shares. (NASDAQ:ALGN). Bbva Compass Bank holds 3,519 shares. Heartland Advisors reported 1.04% stake. 21,106 were accumulated by Dana Investment Advsrs. Walleye Trading Llc accumulated 0.01% or 13,699 shares. Following the sale, the chief financial officer now owns 1,544 shares in the company, valued at $393,720. Creative Planning owns 17,661 shares or 0.02% of their U.S. portfolio.
The Piotroski score is a discrete score ranging from 0-9 that shows nine criteria used to find out the strength of a company's financial position. After $1.01 actual EPS reported by Align Technology, Inc. for the previous quarter, Wall Street now forecasts -4.95% negative EPS growth.
We understand ALGN seems to be overvalued based on its current earnings, compared to its industry peers.